Literature DB >> 30004966

Making the Medicine Go Down: Salt or Sugar?

Ryan M Brown1, Joanna L Stollings, Matthew W Semler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30004966      PMCID： PMC6047761          DOI： 10.1097/CCM.0000000000003229

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  13 in total

1.  Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

Authors:  Anders Perner; Nicolai Haase; Anne B Guttormsen; Jyrki Tenhunen; Gudmundur Klemenzson; Anders Åneman; Kristian R Madsen; Morten H Møller; Jeanie M Elkjær; Lone M Poulsen; Asger Bendtsen; Robert Winding; Morten Steensen; Pawel Berezowicz; Peter Søe-Jensen; Morten Bestle; Kristian Strand; Jørgen Wiis; Jonathan O White; Klaus J Thornberg; Lars Quist; Jonas Nielsen; Lasse H Andersen; Lars B Holst; Katrin Thormar; Anne-Lene Kjældgaard; Maria L Fabritius; Frederik Mondrup; Frank C Pott; Thea P Møller; Per Winkel; Jørn Wetterslev
Journal:  N Engl J Med       Date:  2012-06-27       Impact factor: 91.245

2.  Normal saline to dilute parenteral drugs and to keep catheters open is a major and preventable source of hypernatremia acquired in the intensive care unit.

Authors:  Wai-Ping Choo; A B Johan Groeneveld; Ronald H Driessen; Eleonora L Swart
Journal:  J Crit Care       Date:  2014-02-03       Impact factor: 3.425

3.  Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*.

Authors:  Karthik Raghunathan; Andrew Shaw; Brian Nathanson; Til Stürmer; Alan Brookhart; Mihaela S Stefan; Soko Setoguchi; Chris Beadles; Peter K Lindenauer
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

4.  Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study.

Authors:  J H Waters; A Gottlieb; P Schoenwald; M J Popovich; J Sprung; D R Nelson
Journal:  Anesth Analg       Date:  2001-10       Impact factor: 5.108

5.  Hydroxyethyl starch or saline for fluid resuscitation in intensive care.

Authors:  John A Myburgh; Simon Finfer; Rinaldo Bellomo; Laurent Billot; Alan Cass; David Gattas; Parisa Glass; Jeffrey Lipman; Bette Liu; Colin McArthur; Shay McGuinness; Dorrilyn Rajbhandari; Colman B Taylor; Steven A R Webb
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

Review 6.  Drug incompatibility chemistry.

Authors:  David W Newton
Journal:  Am J Health Syst Pharm       Date:  2009-02-15       Impact factor: 2.637

7.  Balanced Crystalloids versus Saline in Critically Ill Adults.

Authors:  Matthew W Semler; Wesley H Self; Jonathan P Wanderer; Jesse M Ehrenfeld; Li Wang; Daniel W Byrne; Joanna L Stollings; Avinash B Kumar; Christopher G Hughes; Antonio Hernandez; Oscar D Guillamondegui; Addison K May; Liza Weavind; Jonathan D Casey; Edward D Siew; Andrew D Shaw; Gordon R Bernard; Todd W Rice
Journal:  N Engl J Med       Date:  2018-02-27       Impact factor: 91.245

8.  Balanced Crystalloids versus Saline in Noncritically Ill Adults.

Authors:  Wesley H Self; Matthew W Semler; Jonathan P Wanderer; Li Wang; Daniel W Byrne; Sean P Collins; Corey M Slovis; Christopher J Lindsell; Jesse M Ehrenfeld; Edward D Siew; Andrew D Shaw; Gordon R Bernard; Todd W Rice
Journal:  N Engl J Med       Date:  2018-02-27       Impact factor: 91.245

9.  A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.

Authors:  Abeed H Chowdhury; Eleanor F Cox; Susan T Francis; Dileep N Lobo
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

10.  Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS.

Authors:  Andrew D Shaw; Karthik Raghunathan; Fred W Peyerl; Sibyl H Munson; Scott M Paluszkiewicz; Carol R Schermer
Journal:  Intensive Care Med       Date:  2014-10-08       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.